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IS6110-Restriction Fragment Length Polymorphism and 
Spoligotyping Analysis of Mycobacterium tuberculosis Clinical 
Isolates for Investigating Epidemiologic Distribution in Korea 
The Beijing family of Mycobacterium tuberculosis has been emerging in the world. 
However, there are few nationwide data of genotypic distribution in Korea. This study 
aimed to identify the genotypic diversity of clinical isolates of M. tuberculosis and to 
demonstrate the population of Beijing family in Korea. We collected 96 clinical M. 
tuberculosis isolates from 11 university hospitals nationwide in Korea from 2008 to 
2009. We observed 24 clusters in IS6110-RFLP analysis and 19 patterns in 
spoligotyping. Seventy-five isolates were confirmed to be Beijing family. Two isolates 
of the K strain and 12 isolates of the K family strain were also found. We found that 
drug resistance phenotypes were more strongly associated with Beijing family than 
non-Beijing family (P=0.003). This study gives an overview of the distribution of 
genotypes of M. tuberculosis in Korea. These findings indicate that we have to pay 
more attention to control of M. tuberculosis strains associated with the Beijing family. 
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INTRODUCTION
Tuberculosis (TB) remains a worldwide healthcare concern, 
being characterized as an epidemic by the World Health Orga-
nization (WHO). In 2008, there were an estimated 8.9–9.9 mil-
lion incident cases of TB, 9.6–13.3 million prevalent cases, 1.1–
1.7 million deaths among HIV-negative people and an addition-
al 0.45–0.62 million deaths among HIV-positive people (1). In 
Korea, the prevalence of TB was estimated to be 123 per 100,000 
in 2006 (2). The increasing number of drug-resistant Mycobac-Choi GE, et al.  •  Molecular Typing of M. tuberculosis Isolates from Korea
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terium tuberculosis isolates, including multidrug-resistant M. 
tuberculosis (MDR-TB) creates serious problems in clinical se-
ries and whole-country cohorts (3). 
  Genotyping has allowed the association of particular strain 
families of M. tuberculosis with demographic and transmission 
characteristics (4). The IS6110-based restriction fragment length 
polymorphism (RFLP) is the most widely applied test and cur-
rently the standard method for comparing the genetic related-
ness of M. tuberculosis strains. Spoligotyping using the direct 
repeat locus (DR) is useful for both clinical management and 
molecular epidemiologic studies of M. tuberculosis (5).
  For a long time, the Beijing family which may have been en-
demic in China, has been emerging in other parts of the world 
(6). The Beijing M. tuberculosis strains have highly similar mul-
tibanded IS6110-RFLP patterns and identical spoligotyping 
patterns. The family is highly prevalent in East Asia (7, 8). How-
ever, there are few data on the nationwide genotypic distribu-
tion in Korea (8, 9).
  This study aimed to identify the genotypic diversity of clinical 
M. tuberculosis isolates and to demonstrate the prevalence of 
Beijing family strains in Korea using IS6110-RFLP and spoligo-
typing methods.
MATERIALS AND METHODS
Sample collection and bacterial strains
From 2008 to 2009, we collected 96 clinical M. tuberculosis iso-
lates from 11 university hospitals nationwide in Korea (Ajou 
University Hospital, Cheju National University Hospital, Chon-
buk National University Hospital, Chonnam National Universi-
ty Hospital, Hallym University Hospital, Keimyung University 
Hospital, Konyang University Hospital, Pusan National Univer-
sity Hospital, Ulsan University Hospital, Yonsei University Sev-
erance Hospital, and Wonju Christian Hospital). The number of 
isolates from a given hospital was roughly proportional to the 
prevalence of TB in that area, as judged by the annual report on 
TB patient notification in Korea 2007 (10). The source patients 
were 58 men and 38 women TB patients with a mean age of 45 
yr (range 21-78 yr). There were 82 primary TB infections, and 12 
had a history of treatment. In two cases, the status was unknown 
because of follow-up loss. The sites of infection were not speci-
fied. Duplicated isolates from the same patient were excluded.
DNA extraction
Chromosomal DNA was purified by the standardized method 
from Löwenstein-Jensen (L-J) slant-grown colonies (11). Briefly, 
lysozyme (1 mg/mL) was added colony-containing tube and the 
mixture was incubated for 1 hr at 37°C. Next, proteinase K (10 
mg/mL) and 70 μL of 10% sodium dodecyl sulfate were added, 
and incubation was continued for 10 min at 65°C. Then N-ace-
tyl-N,N,N-trimethyl ammonium bromide was added, and the 
mixture was incubated for 10 min at 65°C. An equal volume of 
chloroform-isoamyl alcohol (24:1 vol/vol) was added. After 
centrifugation for 5 min, 0.6 volume of isopropanol was added 
to the supernatant liquid to precipitate the DNA. After 20 min 
at -20°C and centrifugation for 15 min, the pellet was washed 
once with 70% ethanol, and the air-dried pellet was dissolved in 
20 μL of 0.1×Tris-EDTA (TE) buffer.
IS6110-RFLP
All isolates were subjected to IS6110-RFLP analysis by an inter-
nationally standardized method (12). Briefly, the chromosomal 
DNA was restricted with PvuII for RFLP analysis. The digested 
DNA was separated overnight by gel electrophoresis and trans-
ferred from the gel to a positively charged nylon membrane 
(Hybond N1) (Amersham, Buckinghamshire, UK). After hybrid-
ization for repetitive elements with labeled DNA probes, the 
bound probes were detected with an enhanced chemilumines-
cence direct nucleic acid system (Amersham) according to the 
manufacturer’s recommendations. The RFLP patterns were an-
alyzed by GelComparII software (Applied Maths, Korthrijk, 
Belgium) (9).
Spoligotyping
Spoligotyping was carried out using a Combi
TM chip spoligotyp-
ing kit (GeneIn, Inc., Busan, Korea) according to the manufac-
turer’s instructions. Briefly, the DNAs of the whole DR region 
were amplified, and the amplified DNAs were hybridized with 
43 spoligotyping probes as described (13). After the results had 
been converted with binary and octal code, the spoligotypes 
were designated as a cluster and assigned a shared internation-
al type number (SIT) according to the international database, 
SpolDB4 (14). 
Determination and analysis of Beijing family and K strains 
We determined Beijing family strains on the basis of several ge-
netic characteristics. By definition, they have an IS6110 insertion 
A1 band in the origin of replication (corresponding to a 3.36-kb 
band) and show an IS6110 banding pattern similar to that of 
strain Beijing (copy number range 15-26) (15). They contain 
nine spacers from 35 to 43 in the spoligotype pattern (16). The 
Beijing-like family was identified by SpolDB4. K strain (Korean 
M. tuberculosis strain) was also identified, which was previously 
defined as a sublineage of the Beijing strain and has a unique 
ten IS6110 RFLP band pattern (17). The K family was identified 
by the characteristics that had eight to twelve IS6110 bands, and 
more than five bands were as same those of as K strains (17).
Drug susceptibility testing
Antibiotic susceptibility testing was performed at the Korean 
Institute of Tuberculosis by the proportion method using L-J 
medium against 11 antibiotics: isoniazid (INH), rifampin (RIF), Choi GE, et al.  •  Molecular Typing of M. tuberculosis Isolates from Korea
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ethambutol, streptomycin, capreomycin, kanamycin, ofloxacin, 
prothionamide, cycloserine, p-aminosalicylic acid, and rifabu-
tin (18). The drug susceptibility test for pyrazinamide was de-
termined using the pyrazinamidase assay (19).
Statistical analysis 
Data were analyzed with SPSS 12.0 (SPSS Inc., Chicago, IL, USA). 
Categorical variables were compared by Fisher’s exact test. Sig-
nificance was defined as a P value of <0.05.
Ethics statement
This research was exempted from full committee review of Insti-
tutional Review Board at Pusan National University Hospital be-
cause cultured bacterial isolates were used without any identifi-
ers linked to the subjects. 
RESULTS
IS6110-RFLP patterns of 96 strains
The IS6110 copy numbers ranged from 5 to 21 (mode=10) (Fig. 1). 
The majority of the strains (45/96, 46.9%) contained 9-11 cop-
ies. With a 60% similarity threshold, 24 clusters were observed 
in the dendrogram based IS6110-RFLP. A total of 86 isolates 
(89.6%) displayed one of 14 clusters and 10 isolates (10.4%) dis-
played unique patterns. Two pairs of four isolates showed iden-
tical IS6110-RFLP patterns in each pair (solid boxes on right in 
Fig. 1); the source patients for each pair had no epidemiologic 
linkage.
Spoligotyping patterns of 96 strains
Eighteen spoligotyping patterns were observed. Among the iso-
lates, 85 (88.5%) displayed one of 7 spoligotypes and 11 (11.4%) 
displayed unique spoligotypes. According to the SpolDB4, 85 
isolates (88.5%) were classified into nine shared international 
types (SITs), whereas 11 isolates were not classified. Among the 
nine clusters identified by SpolDB4 analysis, the SIT1 cluster 
contained a majority of the isolates (62/96, 64.6%). When con-
sidering all spoligotypes, the Beijing, including the SIT1 cluster, 
was the most prevalent (69/96, 71.9%), followed by seven (7.3%) 
Beijing-like spoligotypes, four (4.2%) CAS family, three (3.1%) U 
family, and two (2.1%) T1 family (Table 1). 
Distribution of Beijing and K strains
When analyzing IS6110-RFLP patterns, 83 of 96 isolates (86.5%) 
Table 1. Results of spoligotyping
Spoligotyping 
   octal codes
SpolDB4 analysis No. of strains
SIT Label Total A1 band
K strain/ 
K family 
000000000003771        1 Beijing 61 61   1/10
000000000003731    190 Beijing  6   5 1/2
000000000003371    265 Beijing  2   2
000000000000771    269 Beijing 
like
 6   6
000000000000731    406 Beijing 
like
 1   1
777777777770771 1,378 CAS  4   2
777777777777771    523 U  3   2
777777777760600    243 T1  1   1
777703777760771 1,223 T1  1
777777777570771 Unclassified  1   1
777777600000200 Unclassified  1
777776777770771 Unclassified  3   1
777776777763771 Unclassified  1
777717776760731 Unclassified  1
774375776563771 Unclassified  1
770777777760731 Unclassified  1   1
703777200000371 Unclassified  1
676773777777600 Unclassified  1
SIT, shared international type from international spoligotype database SpolDB4 (http://
www.pasteur-eloupe.fr:8081/SITVITDemo/); Label, spoligotype families as assigned 
in SpolDB4; A1 band, the number of isolates including IS6110 insertion A1 band in 
the origin of replication (corresponding to a 3.36-kb band); K strain, the number of 
isolates indicating a unique 10 IS6110 RFLP band pattern; K family, the number of 
isolates having 8 to 12 IS6110 bands and more than five bands in the K strains.
Fig. 1. Results of RFLP and spoligotyping of 96 M. tuberculosis isolates. Two solid 
boxes indicate that the two pairs of four isolates showed identical IS6110-RFLP 
patterns in each pair.Choi GE, et al.  •  Molecular Typing of M. tuberculosis Isolates from Korea
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that contained the Beijing-specific A1 insertion band were de-
termined to be Beijing family. However, 75 of these 86 isolates, 
and another isolate with no A1 band were confirmed to be Bei-
jing family by spoligotyping (Fig. 1). These isolates each had 8 
to 21 bands (mode 10). The unique IS6110-RFLP pattern of K 
strain was found in 2 isolates (2.1%), and 12 isolates (12.5%) 
closely resembled the K family strain. Of the 76 Beijing family 
strains, K family strains accounted for 18.4%. 
Relation between genotypes and drug resistances
In this study, 21 isolates were resistant to at least one anti-tu-
berculosis drug. Nine of these were MDR-TB. Nineteen of 21 
isolates resistant to at least one drug and all nine MDR-TB iso-
lates belonged to the Beijing family, meaning there is a signifi-
cantly higher rate of MDR or any drug resistance in the Beijing 
family (P=0.003) (Table 2). The differences in the resistance rates 
between K family and non-K Beijing family were not significant. 
Drug resistance rates in the study population were 9.4% (9/96) 
for MDR-TB and 21.9% (21/96) for at least one drug, including 
INH and RIF. For primary TB cases, the drug resistance rates 
were 2.4% (2/82) for MDR-TB and 15.9% (13/82) for at least one 
drug, including INH and RIF.
DISCUSSION
The Beijing family of M. tuberculosis strains may have been en-
demic in China for a long time (6) and is now emerging in other 
parts of the world. This family is dominant in Asian countries 
such as China (86%), Mongolia (50%), Japan (73%), Indonesia 
(34%), Thailand (44%), and Vietnam (54%) (7, 8, 20-22). It also 
is present in Korea. In a 1995 report, 43% of tested strains (6/14) 
were the Beijing family (8). In another report, 72% (99/138) were 
the Beijing family, which was defined by IS6110-RFLP patterns 
(9). The current study shows a higher rate of the Beijing family 
(79%), nearly same as the rates in China and Japan. In the first 
report from Korea (8), the selection criteria for the tested strains 
were not specified, and the test volume was small. In contrast, 
the two other studies including the current study, examined 
strains from several areas in Korea, and the number of tested 
strains was roughly proportional to the number of TB patients 
reported from each area. Very recently, one report claimed that 
nearly all the isolates in one Korean tertiary TB hospital were 
Beijing family (23). However, this hospital normally recruits drug-
resistant or treatment failure cases from the entire country, so 
the strain population could be distorted. Therefore, our data 
appear to represent the genuine distribution of the Beijing fam-
ily in Korea. Although isolates were collected from 11 university 
hospitals throughout the country, we did not find any associa-
tion between the Beijing family and region. Also, no correlation 
between Beijing family and the sex or age of the patients was 
found. Two pairs of isolates from each of two university hospi-
tals showed identical IS6110-RFLP patterns, but we did not find 
an epidemiological relation between the genotypes of the strains. 
That means that identical IS6110-RFLP patterns do not always 
indicate strains of the same origin.
  The Beijing family organisms have multiple copies of IS6110 
bands (15 to 26), and therefore, differentiation between strains 
is not easy (24, 25). Many other characteristics have been dem-
onstrated to identify the Beijing family by IS6110-RFLP analy-
sis. In the current study, the A1 band in the IS6110 RFLP pattern 
was used to identify 83 strains presumablely as Beijing family, 
of which 76 were confirmed as such by spoligotyping. However, 
19 Beijing reference strains suggested by Kremer et al. and at 
least 450 IS6110 profiles reported by the Public Health Research 
Institute (PHRI) TB Center database were not useful in detect-
ing Beijing strains in this study (data not shown) (24, 26). A den-
drogram of the IS6110-RFLP band pattern was diverse even 
within the Beijing family, showing that the 76 strains belonged 
to 18 clusters. Interestingly, the Beijing family strains tested in 
this study harbored relatively small numbers of IS6110 bands (8 
to 21), indicating that the characteristics of the Beijing family 
isolated in Korea are different from those isolated in other coun-
tries. Mycobacterial interspersed repetitive units (MIRU)-vari-
able number of tandem repeats (VNTR), another molecular 
epidemiologic tool for M. tuberculosis, was introduced to geno-
type M. tuberculosis isolates from Korea (4, 27). The MIRU-VN-
TR is highly discriminatory and easy to use, and can differenti-
ate strains belonged to the Beijing family (4). However, it is not 
suitable for demonstrating the population of Beijing strains be-
cause it cannot provide any information distinguishing Beijing 
from non-Beijing family strains. In previous studies, the domi-
nant M. tuberculosis strains in Korea were defined as the K strain, 
a sublineage of the Beijing strain (17). According to the defini-
tion, two isolates (2.1%) were identified with K strains and 12 
isolates (12.5%) with the K family in the current study. These 
figures are slightly lower than those in the report of Park et al. 
(18.8%) from Korea (28). However, these data were developed 
with strains from one area, Gyeonggi Province; to estimate the 
population of the K family throughout Korea, a large-scale study 
using nationwide collection would be necessary. 
  The effect of Beijing family strains on drug resistance is not 
clear (29), but the Beijing family is reported to have a higher rate 
of resistance (25). We also demonstrated that drug resistance 
Table 2. Spoligotype and drug resistance in 96 M. tuberculosis clinical isolates
Spoligotype No. of isolates (%)   MDR (%) Any drug (%)
Beijing family  76 (79.1)    9 (11.8)*  20 (26.3)*
Non-Beijing family  20 (20.9) 1 (5.0)
Total 96 (100) 9 (9.4) 21 (21.9)
*MDR and any drug resistance rates are significantly higher in Beijing family than in 
non-Beijing family.
MDR, multi-drug resistant; Any drug, resistance to at least one drug, including INH 
and RIF.Choi GE, et al.  •  Molecular Typing of M. tuberculosis Isolates from Korea
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was strongly associated with Beijing family strains in Korea. All 
MDR-TB isolates and the majority (19/21) of the isolates with at 
least one drug resistance belonged to the Beijing family. One 
recent study reported interesting data that in one Korean TB 
hospital, which specializes in caring for patients with drug-re-
sistant TB, 97% of the isolates belonged to the Beijing family (23). 
This suggests a close connection between drug resistance and 
Beijing family membership. Therefore, patients found to be in-
fected with M. tuberculosis of the Beijing family should be mon-
itored closely for drug-taking compliance or response to thera-
py. Spoligotyping analysis could easily classify and be useful to 
detect Beijing strains. The 76 isolates of the Beijing family be-
longed to only five clusters according to the international spoli-
gotype database, SpolDB4. Therefore, when considering that it 
is important to identify Beijing family members, spoligotyping 
can be performed more easily and rapidly than IS6110-RFLP 
analysis. Another issue regarding drug resistance is the primary 
or acquired resistance rate of M. tuberculosis. Bai et al. (30) re-
ported that in 2004, the resistance rates were 2.7% for MDR and 
12.8% for any one drug resistance in new TB cases and 14% for 
MDR and 27.7% for any one drug resistance among patients 
with a history of treatment in Korea. In the current study, the 
drug resistance rates in primary TB cases appeared 2.4% for 
MDR-TB and 15.9% for any one drug resistance, representing a 
similar result with the previous report.
  In summary, this study gives an overview of the distribution 
of genotypes of clinical M. tuberculosis isolates in Korea. Our 
data showed that the Beijing strain currently is the most preva-
lent. Especially, we found an association between Beijing family 
strains and drug resistance phenotypes. These findings indicate 
that we have to pay more attention to control of M. tuberculosis 
strains associated with the Beijing family. Our data also indicate 
that a poor drug treatment outcome may occur more common-
ly in Beijing family strains.
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